Eli Lilly and Docplexus invite you for an interactive LIVE Webinar on 24th February 2022 at 01:00 PM, 04:00 PM, and 10:00 PM GST. In this session, the expert Neurologist, Prof. Piero Barbanti will discuss Real-world effectiveness, safety, and tolerability data of galcanezumab including key results from GARLIT study. Efficacy, safety, and tolerability of galcanezumab across patient populations in clinical trials.
Impact of galcanezumab on total pain burden, interictal burden, and work productivity in clinical trials. We look forward to an informative discussion! PP-GZ-LB-0179
